ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 374 filers reported holding ROYALTY PHARMA PLC in Q2 2024. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $43,957,000 | -58.9% | 1,128,255 | -57.9% | 50.90% | -24.2% |
| Q4 2021 | $106,824,000 | +10.3% | 2,680,644 | 0.0% | 67.12% | +11.2% |
| Q3 2021 | $96,878,000 | -11.8% | 2,680,644 | 0.0% | 60.36% | -16.0% |
| Q2 2021 | $109,880,000 | -6.0% | 2,680,644 | 0.0% | 71.84% | -0.3% |
| Q1 2021 | $116,930,000 | -34.5% | 2,680,644 | -24.8% | 72.07% | -4.6% |
| Q4 2020 | $178,473,000 | – | 3,565,887 | – | 75.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $244,378,000 | 79.54% |
| Vantage Consulting Group Inc | 7,862,542 | $284,152,000 | 60.85% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $96,878,000 | 60.36% |
| Indie Asset Partners, LLC | 701,323 | $25,346,000 | 20.53% |
| HARVARD MANAGEMENT CO INC | 7,142,856 | $258,143,000 | 15.13% |
| Bleichroeder LP | 1,115,980 | $40,332,000 | 6.55% |
| Overbrook Management Corp | 785,132 | $28,375,000 | 6.16% |
| Geo Capital Gestora de Recursos Ltd | 194,305 | $7,022,000 | 3.21% |
| Brown University | 621,759 | $22,470,000 | 3.05% |
| Graypoint LLC | 610,584 | $22,067,000 | 2.71% |